Marinus Pharmaceuticals I... (MRNS)
0.55
0.00 (0.00%)
At close: Feb 10, 2025, 3:59 PM
Marinus Pharmaceuticals Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -1.03 | -1.96 | -1.07 | -1.25 | -0.55 | -0.8 | -2.54 | -0.17 | -1.15 | -1.5 | -3.06 | -11.45 |
| PEG Ratio | -0.00 | 0.02 | -0.08 | 0.03 | -0.05 | -0.07 | 0.06 | 0.01 | 0.21 | -0.01 | -0.01 | n/a |
| PS Ratio | 4.72 | 1.53 | 7.10 | 48.41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 161.27 |
| PB Ratio | 8.72 | 0.34 | 2.04 | 0.61 | 0.34 | 0.43 | 0.83 | 0.23 | 0.61 | 0.40 | 1.71 | 3.86 |
| P/FCF Ratio | -1.24 | -0.34 | -1.87 | -1.37 | -0.6 | -1.05 | -2.49 | -0.19 | -1.39 | -1.89 | -2.43 | -13.07 |
| P/OCF Ratio | -1.24 | -0.34 | -1.96 | -1.37 | -0.61 | -1.05 | -2.55 | -0.2 | -1.42 | -1.89 | -2.43 | -13.13 |
| OCF/S Ratio | -3.81 | -4.43 | -3.62 | -35.46 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.28 |
| Debt / Equity Ratio | 6.58 | 0.63 | 0.76 | 0.00 | 0.01 | n/a | n/a | 0.24 | 0.16 | 0.17 | n/a | 0.64 |
| Quick Ratio | 4.01 | 4.38 | 3.26 | 13.65 | 11.72 | 10.70 | 13.18 | 3.75 | 7.77 | 24.59 | 4.99 | 1.93 |
| Current Ratio | 4.07 | 4.38 | 3.03 | 13.06 | 11.72 | 10.70 | 13.18 | 3.75 | 7.77 | 24.59 | 4.99 | 1.93 |
| Asset Turnover | 0.18 | 0.10 | 0.11 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 |
| Interest Coverage | -7.78 | -10.57 | -37.54 | n/a | n/a | n/a | -119.77 | -60.87 | -51.44 | -101.88 | -59.36 | -4.46 |
| Return on Equity (ROE) | -8.43 | -0.17 | -1.9 | -0.49 | -0.61 | -0.54 | -0.33 | -1.33 | -0.53 | -0.26 | -0.56 | -0.34 |
| Return on Assets (ROA) | -0.83 | -0.08 | -0.74 | -0.44 | -0.54 | -0.49 | -0.31 | -0.91 | -0.42 | -0.22 | -0.45 | -0.16 |
| Return on Capital (ROIC) | -1.01 | -0.55 | -1.01 | -0.49 | -0.6 | -0.54 | -0.33 | -1.21 | -0.47 | -0.25 | -0.57 | -0.34 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 93.76% | 98.67% | 90.37% | -2.84K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100.00% |
| Net Profit Margin | -456.31% | -77.78% | -662.5% | -3.88K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.41K% |
| Pretax Profit Margin | -461.27% | -64.48% | -643.7% | -3.93K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.41K% |
| Operating Profit Margin | -424.3% | -442.69% | -631.68% | -3.95K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.43K% |
| FCF Margin | -381.17% | -450.04% | -380.36% | -3.55K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.23K% |
| EBITDA Margin | -404.97% | -19.96% | -622.53% | -3.89K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.07K% |